Abstract
The aim of this study was to explore the role of variants of the gene encoding arachidonate 5-lipoxygenase-activating protein (ALOX5AP) as possible susceptibility factors for coronary artery disease (CAD) and myocardial infarction (MI) in patients with or without angiographically proven CAD. A total of 1431 patients with or without angiographically documented CAD were examined simultaneously for seven ALOX5AP single-nucleotide polymorphisms, allowing reconstruction of the at-risk haplotypes (HapA and HapB) previously identified in the Icelandic and British populations. Using a haplotype-based approach, HapA was not associated with either CAD or MI. On the other hand, HapB and another haplotype within the same region (that we named HapC) were significantly more represented in CAD versus CAD-free patients, and these associations remained significant after adjustment for traditional cardiovascular risk factors by logistic regression (HapB: odds ratio (OR) 1.67, 95% confidence interval (CI) 1.04–2.67; P=0.032; HapC: OR 2.41, 95% CI 1.09–5.32; P=0.030). No difference in haplotype distributions was observed between CAD subjects with or without a previously documented MI. Our angiography-based study suggests a possible modest role of ALOX5AP in the development of the atheroma rather than in its late thrombotic complications such as MI.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Watkins H, Farrall M : Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 2006; 7: 163–173.
Lusis AJ, Fogelman AM, Fonarow GC : Genetic basis of atherosclerosis, Part I, New genes and pathways. Circulation 2004; 110: 1868–1873.
Wang Q : Molecular genetics of coronary artery disease. Curr Opin Cardiol 2005; 20: 182–188.
Helgadottir A, Manolescu A, Thorleifsson G et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233–239.
Dixon RAF, Diehl RE, Opas E et al: Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 1990; 343: 282–284.
Miller DK, Gillard JW, Vickers PJ et al: Identification and isolation of a membrane protein necessary for leukotriene production. Nature 1990; 343: 278–281.
Spanbroek R, Grabner R, Lotzer K et al: Expanding expression of 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 2003; 100: 1238–1243.
Qiu H, Gabrielsen A, Agardh HE et al: Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006; 103: 8161–8166.
Mehrabian M, Allayee H, Wong J et al: Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002; 91: 120–126.
Zhao L, Funk CD : Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 2004; 14: 191–195.
Löhmussaar E, Gschwendtner A, Mueller JC et al: ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005; 36: 731–736.
Meschia JF, Brott TG, Brown RD et al: Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 2005; 58: 351–361.
Zee RY, Cheng S, Hegener HH, Erlich HA, Ridker PM : Genetic variants of arachidonate 5-lipoxygenase activating protein and risk of incident myocardial infarction and ischemic stroke. Stroke 2006; 37: 2007–2011.
Girelli D, Russo C, Ferraresi P et al: Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774–780.
Devlin B, Risch N : A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311–322.
Lake SL, Lyon H, Tantisira K et al: Estimation and tests of haplotype–environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 56–65.
Gabriel SB, Schaffner SF, Nguyen H et al: The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–2229.
Kajimoto K, Shioji K, Ishida C et al: Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population. Circ J 2005; 69: 1029–1034.
Hansson GK : Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.
Samuelsson B : Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568–575.
Helgadottir A, Manolescu A, Helgason A et al: A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006; 38: 68–74.
Dwyer JH, Allayee H, Dwyer KM et al: Arachidonate 5-lipoxigenase promoter genotype, dietary arachidonic acid and atherosclerosis. N Engl J Med 2004; 350: 29–37.
Funk CD : Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 2005; 4: 664–672.
Steinberg D : At last, direct evidence that lipoxygenases play a role in atherogenesis. J Clin Invest 1999; 103: 1487–1488.
Lötzer K, Funk CD, Habenicht AJR : The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 2005; 1736: 30–37.
Lusis AJ : Atherosclerosis. Nature 2000; 407: 233–241.
Lander ES, Schork NJ : Genetic dissection of complex traits. Science 1994; 265: 2037–2048.
Colhoun HM, McKeigue PM, Davey Smith G : Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865–872.
Helgadottir A, Gretarsdottir S, St Clair D et al: Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005; 76: 505–509.
Acknowledgements
This work was supported by grants from the Veneto Region, Italian Ministry of University and Research (Grant no. 2005/065152), and the Cariverona Foundation, Verona, Italy. We wish to thank Mrs Maria Zoppi for invaluable secretary help, and Mr Diego Minguzzi for technical assistance. The authors declare that they have no potential conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)
Supplementary information
Rights and permissions
About this article
Cite this article
Girelli, D., Martinelli, N., Trabetti, E. et al. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study. Eur J Hum Genet 15, 959–966 (2007). https://doi.org/10.1038/sj.ejhg.5201854
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ejhg.5201854
Keywords
This article is cited by
-
Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population
Lipids in Health and Disease (2019)
-
Weighted Multi-marker Genetic Risk Scores for Incident Coronary Heart Disease among Individuals of African, Latino and East-Asian Ancestry
Scientific Reports (2018)
-
The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis
BMC Cardiovascular Disorders (2015)
-
A Novel Risk Haplotype of ALOX5AP Gene is Associated with Ischemic Stroke in Chinese Han Population
Journal of Molecular Neuroscience (2014)
-
ALOX5AP gene variants show differential association with coronary artery disease in different populations
Journal of Community Genetics (2010)
